A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects
Stopped Due to the COVID-19 epidemic situation, the sponsor has decided to terminate the project.
Conditions
Interventions
- DRUG: STSA-1002 Injection
- DRUG: STSA-1005 Injection
Sponsor
Staidson (Beijing) Biopharmaceuticals Co., Ltd